Back to news

SYK INVESTIGATION: Stryker Investors Should Contact Block & Leviton To Learn How They Might Recover Losses

Newsfile Corp•02/10/2026•16:26 ET
1

Key Highlights

  • ➤Stryker (SYK) shares fell roughly 8% after manufacturing issue remained unresolved
  • ➤July 30, 2026 CEO said manufacturing problem had been "addressed"
  • ➤September 8, 2026 CFO said manufacturing problem would persist into fourth quarter
  • ➤Block & Leviton is investigating potential federal securities law violations

Boston, Massachusetts--(Newsfile Corp. - October 2, 2026) - Block & Leviton is investigating Stryker Corporation (NYSE: SYK) for potential securities law violations. Investors who have lost money in their Stryker investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/syk.

Block & Leviton is investigating whether Stryker Corporation and certain of its executives may have violated federal securities laws. On July 30, 2026, Stryker's CEO told investors that the company had "addressed" a manufacturing problem affecting inventory supply in its peripheral vascular business, an issue management indicated it expected to resolve during the third quarter. On September 8, 2026, however, Stryker's CFO disclosed at the Wells Fargo Healthcare Conference that the manufacturing problem remained unresolved and was now expected to persist into the fourth quarter. Stryker shares fell roughly 8% on the news. The investigation concerns whether Stryker misrepresented the status of the manufacturing problem and the health of its business to investors.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in